In the US alone, 12% of the population have reported using injectable weight loss drugs, such as Wegovy/Ozempic, Zepbound and Saxenda, over the past year. That's more than double the number recorded in early 2024.
In European countries, demand is also on the rise: In the UK, for example, a survey found that 21% of the public had accessed an online or in-person pharmacy in the past year to obtain weight loss medication. Germans, for example, have also been keen to adopt the drugs, even if they have to pay for them themselves, according to a report by Reuters.
Read Article
#Counterfeit
#GLP-1